NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Open Posted

Opportunity number
RFA-EB-28-004
Agency
Applications due
Award size
Not on record

Opportunity facts

Funding instrument
Grant
Category
  • Health
Eligible applicants
  • City/Township Governments
  • State Governments
  • 501(c)(3) Nonprofits
  • County Governments
  • Tribal Organizations (Not Federally Recognized)
  • Independent School Districts
  • Non-501(c)(3) Nonprofits
  • Higher Education Inst. (Public)
  • For Profit Organizations
  • Tribal Governments (Federally Recognized)
  • Special District Governments
  • Higher Education Inst. (Private)
  • Other
  • Small Businesses
  • Public or Indian Housing Auth.

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institutes of Health is soliciting applications to advance the development and translation of next-generation diagnostic and therapeutic devices within the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and Helping to End Addiction Long-term (HEAL) Initiatives, with applications due December 1, 2030. Clinical trials are prohibited under this funding track.

Eligible applicants include small businesses, for-profit organizations, tribal governments (federally and non-federally recognized), higher education institutions (public and private), city and county governments, 501(c)(3) and non-501(c)(3) nonprofits, state governments, independent school districts, housing authorities, federal agencies, U.S. territories and possessions, faith-based and community-based organizations, regional organizations, and non-domestic entities. No cost share requirement is specified.

Funded activities will facilitate translation of new devices up to the stage of readiness for first-in-human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope includes technology development and optimization, and studies to prepare for approvals for human use. Projects must address technology development relevant to prevention, monitoring, diagnosis, and treatment of disorders within both BRAIN and HEAL priorities.

The opportunity is administered jointly by the National Institute of Dental and Craniofacial Research (CFDA 93.121) and the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286). The source does not disclose the award ceiling, award floor, expected number of awards, place of performance, or period of performance details in this forecast notice.

Synopsis

This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Files

File Type Posted
PKG00294447.pdf PDF
RFA-EB-28-004-Full-Announcement.html HTML file

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity